| Orai1 calcium channel inhibition prevents progression of chronic pancreatitis V Szabó, N Csákány-Papp, M Görög, T Madácsy, Á Varga, A Kiss, B Tél, ... JCI insight 8 (13), 2023 | 9 | 2023 |
| Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease … K Judit Szanto, T Madácsy, D Kata, T Ferenci, M Rutka, A Bálint, R Bor, ... Expert Opinion on Biological Therapy 21 (4), 539-548, 2021 | 6 | 2021 |
| P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in inflammatory bowel disease B Jójárt, T Molnár, V Szabó, Á Varga, T Resál, K Szántó, D Kata, I Földesi, ... Journal of Crohn's and Colitis 15 (Supplement_1), S453-S453, 2021 | 3 | 2021 |
| Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology Á Varga, T Madácsy, M Görög, A Kiss, P Susánszki, V Szabó, B Jójárt, ... Cellular and Molecular Life Sciences 80 (7), 192, 2023 | 2 | 2023 |
| Disease modelling of Inflammatory Bowel Disease by human colon organoids T Molnár, B Jójárt, T Resál, K Szántó, D Kata, I Földesi, T Molnár, J Maléth, ... JOURNAL OF CROHNS & COLITIS 15, S155-S155, 2021 | 2 | 2021 |
| Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases B Jójárt, T Resál, D Kata, T Molnár, P Bacsur, V Szabó, Á Varga, ... Journal of Crohn's & Colitis 18 (3), 392, 2024 | 1 | 2024 |
| Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls P Bacsur, M Rutka, A Asbóth, T Resál, K Szántó, B Jójárt, A Bálint, E Ari, ... Therapeutic Advances in Gastroenterology 16, 17562848231174298, 2023 | 1 | 2023 |
| LDN-071, a novel first-in-class amino acid-based PAI-1 inhibitor, significantly reduces the severity of experimental colitis in mice B Jojart, N Csakany-Papp, H Laub, B Vasas, B Barta, V Szabo, ... JOURNAL OF CROHNS & COLITIS 18, I338-I338, 2024 | | 2024 |
| P421 The faecal biomarker LDN-051 is a novel tool for monitoring disease activity and therapeutic response in Inflammatory Bowel Diseases B Jójárt, T Resál, K Diána, T Molnár, P Bacsur, V Szabó, Á Varga, ... Journal of Crohn's and Colitis 18 (Supplement_1), i869-i869, 2024 | | 2024 |
| P072 LDN-071, a novel first-in-class amino acid-based PAI-1 inhibitor, significantly reduces the severity of experimental colitis in mice B Jójárt, N Csákány-Papp, H Laub, B Vasas, B Barta, V Szabó, ... Journal of Crohn's and Colitis 18 (Supplement_1), i342-i342, 2024 | | 2024 |
| Determining the role of Serpin E1/PAI-1 in the development and progression of chronic pancreatitis T Molnár, V Szabó, B Jójárt, N Csákány-Papp, P Pallagi, J Maléth Pancreatology 23, e65, 2023 | | 2023 |
| CFTR activity is determined store-independently by SPCA2/STIM1/ORAI1 complex in secretory epithelial cells A Varga, M Görög, T Madácsy, P Pallagi, V Szabó, A Kiss, P Susánszki, ... Pancreatology 22, e29, 2022 | | 2022 |
| Investigating the role of Orai1 Ca2+ channel in the progress of chronic pancreatitis V Szabó, P Pallagi, N Papp, M Görög, B Tél, B Jójárt, M Molnár, A Varga, ... Pancreatology 22, e28, 2022 | | 2022 |
| Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease B Jójárt, T Molnàr, V Szabó, Á Varga, T Resàl, K Szàntó, D Kata, I Földesi, ... Journal of Crohn's and Colitis 16 (4), 689-689, 2022 | | 2022 |
| Determination of the cytokine pattern of human colon organoids derived from Inflammatory Bowel Disease patients T Molnar, B Jojart, T Resal, K Szanto, D Kata, I Földesi, T Molnar, J Maleth, ... JOURNAL OF CROHNS & COLITIS 16, I173-I173, 2022 | | 2022 |
| P721 Faecal microbiota analysis with body composition and nutritional habits simultaneously amongst Crohn’s disease patients A Balint, P Bacsur, T Resal, B Jojart, Z Gyuris, G Jaksa, L Pinter, B Takacs, ... Journal of Crohn's and Colitis 16 (Supplement_1), i615-i615, 2022 | | 2022 |
| P463 Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease-potential new activity marker B Jojart, T Molnar, D Kata, V Szabo, A Varga, T Resal, P Bacsur, K Szanto, ... Journal of Crohn's and Colitis 16 (Supplement_1), i438-i438, 2022 | | 2022 |
| P713 Gut microbiota alterations after bowel preparation amongst inflammatory bowel disease patients M Rutka, K Szanto, P Bacsur, T Resal, B Jojart, A Balint, E Ari, B Kintses, ... Journal of Crohn's and Colitis 16 (Supplement_1), i609-i609, 2022 | | 2022 |
| Interplay of ORAI1 Ca2+ channel and cystic fibrosis transmembrane conductance regulator (CFTR) in epithelial physiology Á Varga, M Görög, T Madácsy, P Pallagi, V Szabó, A Kiss, B Jójárt, B Tél, ... Pancreatology 21, S10-S11, 2021 | | 2021 |
| Transcriptome analyses of pancreatic ductal organoids revealed cAMP signaling elements T Madácsy, V Szabó, A Kiss, B Jójárt, G Groma, P Pallagi, J Maléth Pancreatology 20, S81-S82, 2020 | | 2020 |
